Key result
The presence of late gadolinium enhancement on cardiovascular magnetic resonance was associated with an increased risk of first hospitalization for heart failure (HR 2.70; 95% CI 1.32-5.50).
Why the study?
Does the presence of late gadolinium enhancement on CMR predict subsequent hospitalization for heart failure in patients referred for CMR?
Cohort (n=1,068)
Does the presence of late gadolinium enhancement on CMR predict subsequent hospitalization for heart failure in patients referred for CMR?
Hazard Ratio: 2.7 (95% CI 1.32–5.5)
The presence and extent of late gadolinium enhancement on CMR is strongly associated with an increased risk of subsequent heart failure hospitalization, independent of LVEF and heart failure stage.
No takes yet. Share an insight, caveat, or question.
May inform HF risk stratification on CMR; leaves open need for prospective validation before practice change.
Wong et al. (2013) conducted a cohort in Patients referred for cardiovascular magnetic resonance (n=1,068). Late gadolinium enhancement (LGE) vs. Absence of LGE was evaluated on First hospitalization for heart failure (HHF) after CMR (HR 2.70, 95% CI 1.32 to 5.50). The presence of late gadolinium enhancement on cardiovascular magnetic resonance was associated with an increased risk of first hospitalization for heart failure (HR 2.70; 95% CI 1.32-5.50).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: